Objective Unlike several other fields of healthcare, little is known about the size of ‘therapist effects’ on patient ...
As biomarker studies employ increasingly complex and expensive genomics and other correlative methods, it is increasingly important to rigorously design these studies and analyze the downstream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results